Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival

被引:19
|
作者
Mastroianni, Riccardo [1 ,2 ]
Brassetti, Ado [1 ]
Krajewski, Wojciech [3 ]
Zdrojowy, Romuald [3 ]
Al Salhi, Yazan [4 ]
Anceschi, Umberto [1 ]
Bove, Alfredo Maria [1 ]
Carbone, Antonio [4 ]
De Nunzio, Cosimo [5 ]
Fuschi, Andrea [4 ]
Ferriero, Mariaconsiglia [1 ]
Nacchia, Antonio [5 ]
Pastore, Antonio Luigi [4 ]
Tema, Giorgia [5 ]
Tuderti, Gabriele [1 ]
Gallucci, Michele [2 ]
Simone, Giuseppe [1 ]
机构
[1] Regina Elena Inst Canc Res, Dept Urol, Via Elio Chianesi 53, I-00154 Rome, RM, Italy
[2] Sapienza Univ, Dept Urol, Rome, Italy
[3] Wroclaw Med Univ, Dept Urol & Urol Oncol, Wroclaw, Poland
[4] Sapienza Univ ICOT, Dept Medico Surg Sci & Biotechnol, Urol Unit, Latina, Italy
[5] St Andrea Hosp, Dept Urol, Rome, Italy
来源
EUROPEAN UROLOGY FOCUS | 2021年 / 7卷 / 06期
关键词
Non-muscle-invasive bladder cancer; Detrusor muscle; Transurethral resection of the bladder; Recurrence-free survival; Low-risk bladder cancer; Intermediate-risk bladder cancer; Low-grade bladder cancer; TRANSURETHRAL RESECTION; EUROPEAN ORGANIZATION; INDIVIDUAL PATIENTS; PROGNOSTIC-FACTORS; STAGE TA; CANCER; RISK; CLASSIFICATION; PROGRESSION; NEOPLASMS;
D O I
10.1016/j.euf.2020.08.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Obtaining detrusor muscle (DM) in transurethral resection of bladder tumor (TURBt) specimen is considered a surrogate marker of resection quality. However, evidence was principally investigated in high-risk tumors. Therefore, DM sampling for low-grade (LG) urothelial carcinoma (UC) remains poorly investigated and certainly requires further investigation. Objective: To assess whether the absence of DM in TURBt specimen has a negative impact on recurrence-free survival (RFS) in patients with a Ta LG UC. Design, setting, and participants: A multicenter TURBt database was queried for "LG, Ta, UC of the bladder." All patients treated between 1996 and 2018 with tumor grade assessed according to both 1973 World Health Organization and 2004 WHO/International Society of Urological Pathology grading classifications and with a minimum follow-up of 1 yr were included. Patients with a previous history of high-grade UC, upper urinary tract UC, or bladder tumor differentiations other than UC were excluded. Intervention: TURBt. Outcome measurements and statistical analysis: Baseline demographic, clinical, and pathologic data were analyzed. The European Organization for Research and Treatment of Cancer (EORTC) risk group was recorded. Kaplan-Meier analysis was performed to assess the predictive role of clinical and pathologic data for RFS. Univariable and multivariable Cox regression analyses were performed to identify the predictors of recurrence. Results and limitations: Overall, 521 patients were included. At Kaplan-Meier analysis, the low-risk cohort displayed significantly higher RFS than the intermediate-risk cohort (1-yr RFS 87% vs 79%; log-rank p = 0.007). At univariable Cox regression analysis, only gender, multiple tumors, tumor diameter >= 3 cm, and EORTC risk group were significant predictors of recurrence. Absence of DM had no impact on RFS. Multivariable Cox regression analysis confirmed gender and EORTC risk group as independent predictors of recurrence. Conclusions: Absence of DM in TURBt specimen has negligible role in RFS of patients with Ta LG tumors of the bladder. Patient summary: In this study, we assessed the role that detrusor muscle (DM) in transurethral resection of bladder tumor specimen has in recurrence-free survival, in patients with a Ta low-grade urothelial carcinoma of the bladder. Absence of DM has no impact on tumor recurrence; therefore, it does not require additional attention. (C) 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1324 / 1331
页数:8
相关论文
共 50 条
  • [41] Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
    Xu, Hao
    Xie, Linguo
    Liu, Xiaoteng
    Zhang, Yu
    Shen, Zhonghua
    Chen, Tao
    Qiu, Xiaoyu
    Sha, Nan
    Xing, Chen
    Wu, Zhouliang
    Hu, Hailong
    Wu, Changli
    ONCOLOGY LETTERS, 2017, 14 (03) : 3522 - 3528
  • [42] Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
    Jin, Subin
    Chang, In Ho
    Kim, Jin Wook
    Whang, Young Mi
    Kim, Ha Jeong
    Hong, Soon Auck
    Lee, Tae-Jin
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (08) : 1327 - +
  • [43] Value of p16INK4a in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology
    Alameda, Francesc
    Juanpere, Nuria
    Pijuan, Lara
    Lloveras, Belen
    Gimeno, Javier
    Baro, Teresa
    Salido, Marta
    Serrano, Sergio
    Lloreta, Josep
    CANCER CYTOPATHOLOGY, 2012, 120 (04) : 276 - 282
  • [44] Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast
    Abel, Mary Kathryn
    Fahrner-Scott, Kelly
    Wong, Jasmine
    Alvarado, Michael
    Ewing, Cheryl
    Esserman, Laura J.
    Park, Catherine
    Mukhtar, Rita A.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (03) : 661 - 667
  • [45] Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast
    Mary Kathryn Abel
    Kelly Fahrner-Scott
    Jasmine Wong
    Michael Alvarado
    Cheryl Ewing
    Laura J. Esserman
    Catherine Park
    Rita A. Mukhtar
    Breast Cancer Research and Treatment, 2020, 183 : 661 - 667
  • [46] Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma
    Yuji Takei
    Suzuyo Takahashi
    Shizuo Machida
    Akiyo Taneichi
    Takahiro Yoshiba
    Yoshifumi Takahashi
    Chikako Yoshida
    Yasushi Saga
    Shigeki Matsubara
    Hiroyuki Fujiwara
    International Journal of Clinical Oncology, 2018, 23 : 930 - 935
  • [47] Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma
    Takei, Yuji
    Takahashi, Suzuyo
    Machida, Shizuo
    Taneichi, Akiyo
    Yoshiba, Takahiro
    Takahashi, Yoshifumi
    Yoshida, Chikako
    Saga, Yasushi
    Matsubara, Shigeki
    Fujiwara, Hiroyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 930 - 935
  • [48] Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma
    Krpina, Kristian
    Babarovic, Emina
    Spanjol, Josip
    Dordevic, Gordana
    Maurer, Tobias
    Jonjic, Nives
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (7-8) : 248 - 252
  • [49] Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally
    Esposito, Andrew
    Jacobs, Daniel
    Ariyan, Stephan
    Galan, Anjela
    Kluger, Harriet
    Clune, James
    Weiss, Sarah
    Thuy Tran
    Olino, Kelly
    ANNALS OF SURGICAL ONCOLOGY, 2021, 29 (1) : 415 - 424
  • [50] De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy
    Nishikawa, Masatomo
    Miyake, Hideaki
    Fujisawa, Masato
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (09) : 417.e9 - 417.e15